770 related items for PubMed ID: 9613778
1. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
Aurlien E, Holte H, Pharo A, Kvaløy S, Jakobsen E, Smeland EB, Kvalheim G.
Bone Marrow Transplant; 1998 May; 21(9):873-8. PubMed ID: 9613778
[Abstract] [Full Text] [Related]
2. Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients.
Aurlien E, Holte H, Kvaløy S, Jakobsen E, Rusten LS, Kvalheim G.
Eur J Haematol Suppl; 2001 Jul; 64():14-20. PubMed ID: 11486395
[Abstract] [Full Text] [Related]
3. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
Moskowitz CH, Glassman JR, Wuest D, Maslak P, Reich L, Gucciardo A, Coady-Lyons N, Zelenetz AD, Nimer SD.
Clin Cancer Res; 1998 Feb; 4(2):311-6. PubMed ID: 9516916
[Abstract] [Full Text] [Related]
4.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
5.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
6. Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
Mayer J, Vásová I, Korístek Z, Navrátil M, Klabusay M, Doubek M, Vorlícek J, Cernilová I, Vodvárka P, Petráková K.
Eur J Haematol Suppl; 2001 Jul; 64():21-7. PubMed ID: 11486396
[Abstract] [Full Text] [Related]
7. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.
Weaver CH, Schwartzberg L, Li W, Hazelton B, West W.
Bone Marrow Transplant; 1996 May; 17(5):715-21. PubMed ID: 8733687
[Abstract] [Full Text] [Related]
8. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
[Abstract] [Full Text] [Related]
9. ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF.
Lee JL, Kim S, Kim SW, Kim EK, Kim SB, Kang YK, Lee J, Kim MW, Park CJ, Chi HS, Huh J, Kim SH, Suh C.
Bone Marrow Transplant; 2005 Mar; 35(5):449-54. PubMed ID: 15654353
[Abstract] [Full Text] [Related]
10. Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease.
McQuaker I, Haynes A, Stainer C, Byrne J, Russell N.
Bone Marrow Transplant; 1999 Oct; 24(7):715-22. PubMed ID: 10516673
[Abstract] [Full Text] [Related]
11. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Haas R, Moos M, Möhle R, Döhner H, Witt B, Goldschmidt H, Murea S, Flentje M, Wannenmacher M, Hunstein W.
Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
[Abstract] [Full Text] [Related]
12. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
Kanteti R, Miller K, McCann J, Roitman D, Morelli J, Hurley C, Berkman E, Schenkein D.
Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
[Abstract] [Full Text] [Related]
13. Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Stamatoullas A, Fruchart C, Bastit D, Boulet D, Moncondult M, Piguet H, Tilly H.
Cancer; 1996 Jun 01; 77(11):2302-7. PubMed ID: 8635099
[Abstract] [Full Text] [Related]
14. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma.
Stiff P, Gingrich R, Luger S, Wyres MR, Brown RA, LeMaistre CF, Perry J, Schenkein DP, List A, Mason JR, Bensinger W, Wheeler C, Freter C, Parker WRL, Emmanouilides C.
Bone Marrow Transplant; 2000 Sep 01; 26(5):471-81. PubMed ID: 11019835
[Abstract] [Full Text] [Related]
15.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
16. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.
Haas R, Hohaus S, Egerer G, Ehrhardt R, Witt B, Hunstein W.
Bone Marrow Transplant; 1992 Jun 01; 9(6):459-65. PubMed ID: 1352717
[Abstract] [Full Text] [Related]
17. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
Smith RJ, Sweetenham JW.
Exp Hematol; 1995 Dec 01; 23(14):1581-8. PubMed ID: 8542950
[Abstract] [Full Text] [Related]
18. Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma.
Magagnoli M, Sarina B, Balzarotti M, Castagna L, Timofeeva I, Nozza A, Bertuzzi A, Siracusano L, Sinnone M, Santoro A.
Bone Marrow Transplant; 2001 Nov 01; 28(10):923-7. PubMed ID: 11753545
[Abstract] [Full Text] [Related]
19. A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
Russell N, Mesters R, Schubert J, Boogaerts M, Johnsen HE, Canizo CD, Baker N, Barker P, Skacel T, Schmitz N.
Haematologica; 2008 Mar 01; 93(3):405-12. PubMed ID: 18268285
[Abstract] [Full Text] [Related]
20. Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis.
Zeller W, Gutensohn K, Stockschläder M, Dierlamm J, Kröger N, Koehne G, Hummel K, Kabisch H, Weh HJ, Kühnl P, Hossfeld DK, Zander AR.
Bone Marrow Transplant; 1996 May 01; 17(5):709-13. PubMed ID: 8733686
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
